Skip to main content
Top
Published in: Rheumatology International 8/2014

01-08-2014 | Original Article

Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study

Authors: Mozhgan Afkhamizadeh, Maryam Sahebari, Seyyed-Reza Seyyed-Hoseini

Published in: Rheumatology International | Issue 8/2014

Login to get access

Abstract

Rheumatoid arthritis (RA), the most prevalent autoimmune arthritis worldwide, usually presents with a circannual manner and, meanwhile, follows a circadian rhythm for symptoms like morning stiffness. Therefore, association between RA and some hormones such as melatonin (MLT) and vitamin D, whose serum values are related to body circadian rhythms or seasonal variations, has become more noticeable recently. Since some studies proposed that RA patients show altered MLT circadian rhythms, especially in concordance with symptoms, in this research, we present the correlation between MLT serum values and RA disease activity score (DAS28ESR). The current cross-sectional study was carried out on 80 volunteers (60 patients and 20 healthy controls). Fifty percent of the participants in each group were sampled in cold, and the same percentage were sampled in warm seasons at 8 a.m. Disease activity was estimated utilizing DAS28ESR. Patients with possible known confounders of MLT secretion were excluded. A commercial MLT ELISA kit was employed to measure MLT. Statistical analysis was conducted by SPSS-11 software. This study outlined higher serum values of MLT in RA patients compared with controls (P = 0.006, z = −2.73). However, MLT did not correlate with DAS in patients (P = 0.45, r = −0.09). GLM analysis demonstrated that DAS28ESR, age, disease duration, medications, gender, and season of sampling had no influence on serum MLT. However, newly diagnosed RA patients presented higher MLT values than established ones (P = 0.03, t = −2.2). A cutoff point value of 23 pg/mL (63.3 % sensitivity and 90 % specificity) for MLT was computed between patients and controls. This study denoted that morning MLT serum values are higher in RA patients than in healthy volunteers. However, MLT and RA disease activity or other disease characteristics do not correlate. MLT serum values were higher in newly diagnosed RA patients than established ones.
Literature
2.
go back to reference Firestein GS (2005) Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. JCR 11:S39–S44PubMed Firestein GS (2005) Immunologic mechanisms in the pathogenesis of rheumatoid arthritis. JCR 11:S39–S44PubMed
3.
go back to reference Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399–408PubMedCrossRef Straub RH, Cutolo M (2007) Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum 56:399–408PubMedCrossRef
4.
go back to reference Cutolo M, Maestroni G, Otsa K et al (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216PubMedCentralPubMedCrossRef Cutolo M, Maestroni G, Otsa K et al (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216PubMedCentralPubMedCrossRef
5.
go back to reference Forrest CM, Mackay GM, Stoy N et al (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526PubMedCentralPubMedCrossRef Forrest CM, Mackay GM, Stoy N et al (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526PubMedCentralPubMedCrossRef
6.
go back to reference Cutolo M, Villaggio B, Candido F et al (1999) Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cellsa. Ann N Y Acad Sci 876:246–254PubMedCrossRef Cutolo M, Villaggio B, Candido F et al (1999) Melatonin influences interleukin-12 and nitric oxide production by primary cultures of rheumatoid synovial macrophages and THP-1 cellsa. Ann N Y Acad Sci 876:246–254PubMedCrossRef
8.
go back to reference Cutolo M, Villaggio B, Otsa K et al (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptoms. Autoimmun Rev 4:497–502PubMedCrossRef Cutolo M, Villaggio B, Otsa K et al (2005) Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease’s symptoms. Autoimmun Rev 4:497–502PubMedCrossRef
9.
go back to reference Maestroni GJ, Sulli A, Pizzorni C et al (2002) Melatonin in rheumatoid arthritis. Ann N Y Acad Sci 966:271–275PubMedCrossRef Maestroni GJ, Sulli A, Pizzorni C et al (2002) Melatonin in rheumatoid arthritis. Ann N Y Acad Sci 966:271–275PubMedCrossRef
10.
go back to reference Saraux A, Berthelot JM, Chalès G et al (2001) Ability of the American College of rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients 2 years later. Arthritis Rheum 44:2485–2491PubMedCrossRef Saraux A, Berthelot JM, Chalès G et al (2001) Ability of the American College of rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients 2 years later. Arthritis Rheum 44:2485–2491PubMedCrossRef
11.
go back to reference Prevoo M, Van’t Hof M, Kuper H et al (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo M, Van’t Hof M, Kuper H et al (1995) Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRef
12.
go back to reference Mayeda A, Mannon S, Hofstetter J et al (1998) Effects of indirect light and propranolol on melatonin levels in normal human subjects. Psychiatry Res 81:9–17PubMedCrossRef Mayeda A, Mannon S, Hofstetter J et al (1998) Effects of indirect light and propranolol on melatonin levels in normal human subjects. Psychiatry Res 81:9–17PubMedCrossRef
13.
go back to reference Wright KP Jr, Badia P, Myers BL et al (1997) Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res 747(1):78–84PubMedCrossRef Wright KP Jr, Badia P, Myers BL et al (1997) Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res 747(1):78–84PubMedCrossRef
14.
go back to reference Maestroni GJ, Cardinali DP, Esquifino AI et al (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111PubMedCrossRef Maestroni GJ, Cardinali DP, Esquifino AI et al (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158:106–111PubMedCrossRef
15.
go back to reference Sulli A, Maestroni G, Villaggio B et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–283PubMedCrossRef Sulli A, Maestroni G, Villaggio B et al (2002) Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci 966:276–283PubMedCrossRef
16.
go back to reference Hansson I, Holmdahl R, Mattsson R (1992) The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 39:23–30PubMedCrossRef Hansson I, Holmdahl R, Mattsson R (1992) The pineal hormone melatonin exaggerates development of collagen-induced arthritis in mice. J Neuroimmunol 39:23–30PubMedCrossRef
20.
go back to reference Nah SS, Won HJ, Park HJ et al (2009) Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J Pineal Res 47:70–74PubMedCrossRef Nah SS, Won HJ, Park HJ et al (2009) Melatonin inhibits human fibroblast-like synoviocyte proliferation via extracellular signal-regulated protein kinase/P21(CIP1)/P27(KIP1) pathways. J Pineal Res 47:70–74PubMedCrossRef
21.
go back to reference El-Awady HM, El-Wakkad AS, Saleh MT et al (2007) Serum melatonin in juvenile rheumatoid arthritis: correlation with disease activity. Pak J Biol Sci 10:1471–1476PubMedCrossRef El-Awady HM, El-Wakkad AS, Saleh MT et al (2007) Serum melatonin in juvenile rheumatoid arthritis: correlation with disease activity. Pak J Biol Sci 10:1471–1476PubMedCrossRef
22.
go back to reference Waldhauser F, Weiszenbacher G, Tatzer E et al (1988) Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 66:648–652PubMedCrossRef Waldhauser F, Weiszenbacher G, Tatzer E et al (1988) Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 66:648–652PubMedCrossRef
23.
go back to reference Cutolo M (2012) Chronobiology and the treatment of rheumatoid arthritis. Curr Opin Rheumatol 24:312–318PubMedCrossRef Cutolo M (2012) Chronobiology and the treatment of rheumatoid arthritis. Curr Opin Rheumatol 24:312–318PubMedCrossRef
Metadata
Title
Morning melatonin serum values do not correlate with disease activity in rheumatoid arthritis: a cross-sectional study
Authors
Mozhgan Afkhamizadeh
Maryam Sahebari
Seyyed-Reza Seyyed-Hoseini
Publication date
01-08-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2930-x

Other articles of this Issue 8/2014

Rheumatology International 8/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine